Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.

Braschi-Amirfarzan, Marta; Tirumani, Sree Harsha; Hodi, Frank Stephen; Nishino, Mizuki

Braschi-Amirfarzan, Marta; Tirumani, Sree Harsha; Hodi, Frank Stephen; Nishino, Mizuki.

Afiliación

Braschi-Amirfarzan M; Department of Radiology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA.
Tirumani SH; Department of Radiology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA.
Hodi FS; Department of Medical Oncology and Medicine, Dana Farber Cancer Institue, Boston, MA 02215, USA.
Nishino M; Department of Radiology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA.

Korean J Radiol ; 18(1): 42-53, 2017.

Article en En | MEDLINE | ID: mdl-28096717

Asunto(s)

Anticuerpos Monoclonales/uso terapéutico; Antineoplásicos/uso terapéutico; Inmunoterapia/métodos; Neoplasias/diagnóstico por imagen; Neoplasias/terapia; Anticuerpos Monoclonales/efectos adversos; Antineoplásicos/efectos adversos; Antígeno B7-H1/inmunología; Antígeno CTLA-4/inmunología; Humanos; Inmunoterapia/efectos adversos; Neoplasias/inmunología; Medicina de Precisión/métodos; Receptor de Muerte Celular Programada 1/inmunología

Palabras clave

Immune-checkpoint inhibitor; Immune-related Response Criteria; Response; Toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia / Anticuerpos Monoclonales / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Korean J Radiol Asunto de la revista: RADIOLOGIA Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google